UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
57 hedge funds and large institutions have $133M invested in Unity Biotechnology in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
48% less capital invested
Capital invested by funds: $258M → $133M (-$125M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $97K
Holders
57
Holding in Top 10
–
Calls
–
Puts
$97K
Top Buyers
| 1 | +$5.68M | |
| 2 | +$3.03M | |
| 3 | +$3.02M | |
| 4 |
Millennium Management
New York
|
+$693K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$405K |
Top Sellers
| 1 | -$5.63M | |
| 2 | -$2.44M | |
| 3 | -$1.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$491K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$474K |